Shortage of Contrast for Imaging Services

Because of a global shortage of iodinated contrast material (Omnipaque) caused by temporary overseas manufacturing disruptions, ChristianaCare is taking steps to preserve supply so that it remains available for the most time-sensitive and urgent patient needs. (Learn more in our frequently asked questions.)

Omnipaque contrast is the most widely used contrast material for CT scans and radiographic examinations at ChristianaCare facilities. It is also used for cardiac imaging and interventions, and in the GI lab, Surgicenter and other settings.

The shortage is expected to last several weeks, and likely into the summer months.

Hospitals and health care organizations worldwide are managing the effects of the shortage and the impact to patient care.

ChristianaCare is making every effort to meet the needs of patients who need this product in their procedures. We are working individually with physicians to prioritize those patients with the most urgent needs.

Wherever possible, we are using alternative contrast material and limiting its use to ensure adequate supplies for time sensitive and emergent exams. It is possible that some elective procedures that use this product will need to be delayed.

ChristianaCare will continue to look for options to minimize disruptions created by the shortage, as we serve our community as expert, caring partners in health.

Learn more in our frequently asked questions (FAQs).

COVID-19: New Visitation Guidelines. Click here for what to expect at ChristianaCare during COVID-19.

Surgery and appointment information – Learn more

For the safety of our patients and caregivers, we have expanded and changed how we deliver care to reduce the spread of COVID-19.

Depending on your medical needs, your appointments could take place in-person, by phone or by video. There may be times when an appointment or procedure may be rescheduled. In which case, we will contact you to let you know. Rest assured, all urgent needs will be addressed promptly.

Existing ChristianaCare patients can request an appointment using their patient portal account.

Visitor restrictions are still in place for your protection. Please refer to our visitor policy for more details.

Our operating rooms are now accommodating elective procedures.

As an added safety measure, all patients will be screened for COVID-19. If needed, your doctor will order a COVID-19 test to be performed at a ChristianaCare laboratory three to five days before your procedure.

ChristianaCare

Shortage of Contrast for Imaging Services

Because of a global shortage of iodinated contrast material (Omnipaque) caused by temporary overseas manufacturing disruptions, ChristianaCare is taking steps to preserve supply so that it remains available for the most time-sensitive and urgent patient needs. (Learn more in our frequently asked questions.)

Omnipaque contrast is the most widely used contrast material for CT scans and radiographic examinations at ChristianaCare facilities. It is also used for cardiac imaging and interventions, and in the GI lab, Surgicenter and other settings.

The shortage is expected to last several weeks, and likely into the summer months.

Hospitals and health care organizations worldwide are managing the effects of the shortage and the impact to patient care.

ChristianaCare is making every effort to meet the needs of patients who need this product in their procedures. We are working individually with physicians to prioritize those patients with the most urgent needs.

Wherever possible, we are using alternative contrast material and limiting its use to ensure adequate supplies for time sensitive and emergent exams. It is possible that some elective procedures that use this product will need to be delayed.

ChristianaCare will continue to look for options to minimize disruptions created by the shortage, as we serve our community as expert, caring partners in health.

Learn more in our frequently asked questions (FAQs).

COVID-19: New Visitation Guidelines. Click here for what to expect at ChristianaCare during COVID-19.

Surgery and appointment information – Learn more

For the safety of our patients and caregivers, we have expanded and changed how we deliver care to reduce the spread of COVID-19.

Depending on your medical needs, your appointments could take place in-person, by phone or by video. There may be times when an appointment or procedure may be rescheduled. In which case, we will contact you to let you know. Rest assured, all urgent needs will be addressed promptly.

Existing ChristianaCare patients can request an appointment using their patient portal account.

Visitor restrictions are still in place for your protection. Please refer to our visitor policy for more details.

Our operating rooms are now accommodating elective procedures.

As an added safety measure, all patients will be screened for COVID-19. If needed, your doctor will order a COVID-19 test to be performed at a ChristianaCare laboratory three to five days before your procedure.

Helen F. Graham Cancer Center
& Research Institute

Thoracic Surgery & Interventional Pulmonology

Expert specialists, leading-edge technology, personalized care

 

Click here to learn more about low-dose CT scans and our Lung Health Screening Program

If you have a complex condition of the lung, esophagus, mediastinum or chest, ChristianaCare’s thoracic surgery and interventional pulmonology team streatmlines world-class services and unmatched experience for the best possible care.

  • Highly trained, experienced specialists.
  • Precision-driven minimally invasive technology.
  • Personalized treatment plans.

Leading-edge technological advantages

If you need thoracic surgery, it is important to choose a team that is experienced with today’s sophisticated technology. Our surgeons do more procedures using da Vinci robotic-assisted technology and minimally invasive video-assisted thoracoscopic surgery than any other program in Delaware. We will take the time to explain your diagnosis, help you explore treatment options and guide you towards a treatment plan with your specific needs in mind.

A dedicated approach to cancer care

Our specialists participate in multi-disciplinary clinics at the Helen F. Graham Cancer Center & Research Institute to provide comprehensive, advanced treatment option for patients with lung, esophageal and other cancers of the chest. ChristianaCare was an early leader in this multi-disciplinary approach that brings together the expertise of surgeons, medical oncologists and radiation oncologists to provide the best possible, personalized treatment plan for each individual.

Leading the way to treatment advances

Our specialists actively publish in national journals and participate in clinical research trials to provide patients with the most cutting-edge treatment options. We partner with the Wistar Institute of Philadelphia to develop translational research projects that can directly benefit patients in the future. Our physicians hold faculty appointments and train resident physicians.

At ChristianaCare, we are committed to providing expert, personalized care to help you breathe easier and get you back to what you love doing most.

Services provided:

  • Advanced bronchoscopic and pleural procedures.
  • Endobronchial lung volume reduction for COPD.
  • Robotic/minimally invasive surgery for lung cancer, including lobectomy and segmentectomy.
  • Robotic/minimally invasive surgery for esophageal cancer.
  • Robotic/minimally invasive surgery for thymic cancers and other chest malignancies.
  • Robotic/minimally invasive hiatal hernia repair and anti-reflux surgery.
  • Treatment of esophageal dysmotility and advanced endoscopic procedures.
  • Robotic first rib resection for thoracic outlet syndrome.

Endobronchial Lung Volume Reduction

Available in Delaware only at ChristianaCare!

With endobronchial lung volume reduction — a newly FDA-approved breakthrough nonsurgical valve placement procedure for severe emphysema available in Delaware only at ChristianaCare — tiny, one-way valves block off diseased parts of the lung so healthier lung tissue can expand and take in more air. Clinical studies show that almost immediately patients are able to:

  • Breathe easier.
  • Be more active and energetic.
  • Experience less shortness of breath.
  • Enjoy a significantly improved quality of life compared to untreated patients.

Ask your pulmonologist, or call us at 302-623-4530 to see if this breakthrough procedure is right for you.

Thoracic Surgery & Interventional Pulmonology
Helen F. Graham Cancer Center & Research Institute
4701 Ogletown-Stanton Road, Newark, DE 19713 directions
302-623-4530